Prednisolone acetate and Oncovin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Prednisolone acetate (prednisolone acetate) and Oncovin (vincristine sulfate). Common drug interactions include cerebral infarction among females and drug-induced liver injury among males.
The phase IV clinical study analyzes what interactions people have when they take Prednisolone acetate and Oncovin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Prednisolone acetate?
Prednisolone acetate has active ingredients of prednisolone acetate. It is often used in uveitis. eHealthMe is studying from 8,151 Prednisolone acetate users. Check the latest studies of Prednisolone acetate.
What is Oncovin?
Oncovin has active ingredients of vincristine sulfate. eHealthMe is studying from 6,667 Oncovin users. Check the latest studies of Oncovin.
26 people who take Prednisolone acetate and Oncovin together, and have interactions are studied.

What are the common drug interactions of Prednisolone Acetate and Oncovin, by gender? *:
female:
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Hyperkalaemia (damage to or disease of the kidney)
- Abdominal pain
- Adult t-cell lymphoma/leukaemia (cancer of the immune system's own t-cells)
- Altered state of consciousness (altered state of mind)
- Ascites (accumulation of fluid in the abdominal cavity)
- Cardiomegaly (increased size of heart than normal)
- Device dislocation
- Diarrhoea
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
male:
- Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
- Myelosuppression (a decrease in the production of blood cells)
- Hepatic failure (liver failure)
- Melaena (the passage of black, tarry stools)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Pyrexia (fever)
- Tracheal haemorrhage (bleeding from trachea)
- Haptoglobin decreased
- Alanine aminotransferase increased
- Anaemia (lack of blood)
What are the common drug interactions of Prednisolone Acetate and Oncovin, by age (0-1 to 60+)? *:
0-1:
- Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
2-9:
- Blood pressure increased
- Bone marrow failure
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Hepatic failure (liver failure)
- Melaena (the passage of black, tarry stools)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Tracheal haemorrhage (bleeding from trachea)
- Abdominal pain
- Altered state of consciousness (altered state of mind)
- Diarrhoea
10-19:
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Pancreatic pseudocyst (collection of tissue and fluids that forms on pancreas)
- Pancreatitis acute (sudden inflammation of pancreas)
20-29:
n/a
30-39:
- Pneumonia
- Pulmonary alveolar haemorrhage (acute bleeding)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
40-49:
n/a
50-59:
- Adult t-cell lymphoma/leukaemia (cancer of the immune system's own t-cells)
- Drug ineffective
- Multi-organ failure (multisystem organ failure)
- Strongyloidiasis (infection with strongyloides stercoralis)
60+:
- Myelosuppression (a decrease in the production of blood cells)
- Nausea (feeling of having an urge to vomit)
- Alanine aminotransferase increased
- Anaemia (lack of blood)
- Decreased appetite
- Malaise (a feeling of general discomfort or uneasiness)
- Neuropathy peripheral (surface nerve damage)
- Neutropenia (an abnormally low number of neutrophils)
- Thrombocytopenia (decrease of platelets in blood)
- Vomiting
What are the existing conditions these people have? *
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 23.08%
- Lymphoma (cancer that begins in immune system cells): 3 people, 11.54%
- Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 3 people, 11.54%
- Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 3 people, 11.54%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 7.69%
- Histology Abnormal: 2 people, 7.69%
- Febrile Neutropenia (fever with reduced white blood cells): 2 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Prednisolone acetate and Oncovin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Prednisolone acetate (8,151 reports)
- Oncovin (6,667 reports)
Browse all drug interactions of Prednisolone acetate and Oncovin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Prednisolone acetate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Oncovin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Prednisolone acetate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Oncovin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on prednisolone acetate and vincristine sulfate (the active ingredients of Prednisolone acetate and Oncovin, respectively), and Prednisolone acetate and Oncovin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lisinopril cause Pulmonary Haemorrhage? - 2 seconds ago
- Drug interactions of Losartan Potassium and Fludrocortisone Acetate - 6 seconds ago
- Could Hyrimoz cause Dementia? - 17 seconds ago
- Seborrhea and drugs of ingredients of simvastatin - 20 seconds ago
- Tecfidera and Loss Of Coordination for Women aged 50-59 - 21 seconds ago
- Tecfidera and Lack Of Coordination for Women aged 50-59 - 22 seconds ago
- Tecfidera and Incoordination And Irregularity Of Voluntary Movements for Women aged 50-59 - 22 seconds ago
- Tecfidera and Coordination Impairment for Women aged 50-59 - 22 seconds ago
- Tecfidera and Clumsiness for Women aged 50-59 - 23 seconds ago
- Tecfidera and Ataxia for Women aged 50-59 - 23 seconds ago